View More Recent Stories

Dec 17, 2024 04:01PM Structure Therapeutics (GPCR) Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity
Nov 18, 2024 02:10PM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)
Oct 21, 2024 07:57AM BMO Capital Reiterates Outperform Rating on Structure Therapeutics (GPCR)
Sep 23, 2024 03:15AM Morgan Stanley Starts Structure Therapeutics (GPCR) at Overweight
Sep 17, 2024 04:05PM Structure Therapeutics (GPCR) Strengthens Executive Team with Promotion of Blai Coll, M.D., Ph.D. to Chief Medical Officer and Appointment of Ashley Hall, J.D. as Chief Development Officer
Sep 17, 2024 04:05PM Structure Therapeutics (GPCR) Appoints Blai Coll as Chief Medical Officer, Ashley Hall as Chief Development Officer
Sep 10, 2024 07:48AM Piper Sandler Reiterates Overweight Rating on Structure Therapeutics (GPCR)
Sep 7, 2024 08:00PM Here's the list of biotech stocks that have key data catalysts in 2025
Jun 26, 2024 04:00PM BMO Capital Reiterates Outperform Rating on Structure Therapeutics (GPCR)
View More Recent Stories